Pregled bibliografske jedinice broj: 1050328
Improvement of endothelial function by pitavastatin: a meta-analysis
Improvement of endothelial function by pitavastatin: a meta-analysis // Expert opinion on pharmacotherapy, 19 (2018), 3; 279-286 doi:10.1080/14656566.2018.1428560 (međunarodna recenzija, pregledni rad, stručni)
CROSBI ID: 1050328 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Improvement of endothelial function by pitavastatin:
a meta-analysis
Autori
Katsiki, Niki ; Reiner, Željko ; Tedeschi Reiner, Eugenia ; Al-Rasadi, Khalid ; Pirro, Matteo ; Mikhailidis, Dimitri P. ; Sahebkar, Amirhossein
Izvornik
Expert opinion on pharmacotherapy (1465-6566) 19
(2018), 3;
279-286
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, stručni
Ključne riječi
Pitavastatin ; endothelial function ; flow-mediated dilation ; atherosclerosis ; meta-analysis
Sažetak
Objective. Dyslipidemia is commonly associated with endothelial dysfunction and increased cardiovascular risk. Pitavastatin has been shown to reduce total and low-density lipoprotein cholesterol, to increase high- density lipoprotein (HDL)-cholesterol and improve HDL function. Furthermore, several trials explored its effects on flow-mediated dilation (FMD), as an index of endothelial function. The authors evaluated the effect of pitavastatin therapy on FMD.Methods. The authors performed a systematic review and meta- analysis of all clinical trials exploring the impact of pitavastatin on FMD. The search included PubMed-Medline, Scopus, ISI Web of Knowledge and Google Scholar databases. Quantitative data synthesis was performed using a random-effects model, with weighted mean difference (WMD) and 95% confidence interval (CI) as summary statistics.Results. Six eligible studies comprising 7 treatment arms were selected for this meta-analysis. Overall, WMD was significant for the effect of pitavastatin on FMD (2.45%, 95% CI: 1.31, 3.60, p<0.001) and the effect size was robust in the leave-one-out sensitivity analysis.Conclusion. This meta-analysis of all available clinical trials revealed a significant increase of FMD induced by pitavastatin
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE